glp 1 receptor agonists incretin mimetics Incretin-Based Therapies Through the Decades: Molecular Innovations and Clinical Impact Frontiers | Mechanisms of action

325 , F448F456 (2023)

doi: 10.1038/s41467-018-04222-8 109 QuD.HouZ.LiJ.LuoL.SuS.YeZ.et al

Timothy Garvey, M.D., co-author of a study published in JAMA (February 2022) and Butterworth Professor of Medicine in the Department of Nutrition Sciences, shared his insights: We have not seen this degree of weight loss with any previous medication. Not only is Semaglutide known for its success in treating type 2 diabetes, but it is proving to be just as effective for weight lossa double benefit in reducing weight and regulating blood sugar levels

Rexin-G, a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: a case report